Reply letter to "Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal"

被引:1
|
作者
Hadigal, Sanjay [1 ]
Colombo, Laura [2 ]
Cook, Joseph [3 ]
机构
[1] Viatris, Dept Med Affairs, Bangalore, India
[2] Viatris, Dept Med Affairs, Monza, Italy
[3] Viatris, Dept Med Affairs, Canonsburg, PA USA
关键词
D O I
10.1080/13696998.2023.2237379
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:933 / 934
页数:2
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States
    Clements, Karen M.
    Meier, Genevieve
    McGarry, Lisa J.
    Pruttivarasin, Narin
    Misurski, Derek A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (05) : 1171 - 1180
  • [22] Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium
    Lieven Annemans
    Vanessa Rémy
    James Oyee
    Nathalie Largeron
    PharmacoEconomics, 2009, 27 : 231 - 245
  • [23] Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium
    Annemans, Lieven
    Remy, Vanessa
    Oyee, James
    Largeron, Nathalie
    PHARMACOECONOMICS, 2009, 27 (03) : 231 - 245
  • [24] Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain
    Ruiz-Aragon, Jesus
    Marquez-Pelaez, Sergio
    Gani, Ray
    Alvarez, Piedad
    Guerrero-Luduena, Richard
    VACCINES, 2022, 10 (02)
  • [25] AN ECONOMIC MODEL TO ESTIMATE THE COST-EFFECTIVENESS OF TRIVALENT INFLUENZA VACCINE HIGH DOSE FOR THE ELDERLY POPULATION IN ENGLAND AND WALES
    Jacob, J.
    Bianic, F.
    Skinner, L.
    Carroll, S.
    Bricout, H.
    Largeron, N.
    Alvarez, F. P.
    Clark-Wright, J.
    VALUE IN HEALTH, 2018, 21 : S225 - S225
  • [26] PUBLIC HEALTH BENEFIT OF SWITCHING TO HIGH DOSE QUADRIVALENT VACCINE FOR INFLUENZA SEASONAL VACCINATION IN PORTUGUESE ELDERLY POPULATION
    Borges, M.
    Lopes, R.
    Bricout, H.
    Martins, M.
    de Courville, C.
    Silva Miguel, L.
    VALUE IN HEALTH, 2022, 25 (01) : S29 - S30
  • [27] The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
    Kohli, Michele A.
    Maschio, Michael
    Mould-Quevedo, Joaquin F.
    Drummond, Michael
    Weinstein, Milton C.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4603 - 4610
  • [28] Effectiveness and cost-effectiveness of influenza vaccination for elderly people
    Sugishita, Yoshiyuki
    Sugawara, Tamie
    VACCINE, 2021, 39 (52) : 7531 - 7540
  • [29] COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINATION PROGRAM FOR THE ELDERLY AGED 65 YEARS OR OLDER IN TAIWAN
    Yang, M. C.
    Tan, C. H.
    VALUE IN HEALTH, 2014, 17 (03) : A276 - A276
  • [30] Cost-effectiveness of influenza vaccination of elderly in Sweden
    Wolff, Ellen
    Larsson, S.
    Roth, A.
    Bastami, S.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2016, 26 : 28 - 28